A detailed history of De Dora Capital, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, De Dora Capital, Inc. holds 6,109 shares of JNJ stock, worth $1.01 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
6,109
Previous 6,034 1.24%
Holding current value
$1.01 Million
Previous $954,000 6.5%
% of portfolio
0.28%
Previous 0.31%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

BUY
$144.38 - $157.78 $10,828 - $11,833
75 Added 1.24%
6,109 $892,000
Q1 2024

Apr 16, 2024

BUY
$155.22 - $162.74 $3,414 - $3,580
22 Added 0.37%
6,034 $954,000
Q4 2023

Jan 18, 2024

BUY
$145.6 - $158.88 $7,134 - $7,785
49 Added 0.82%
6,012 $942,000
Q3 2023

Oct 18, 2023

BUY
$155.75 - $174.48 $7,008 - $7,851
45 Added 0.76%
5,963 $928,000
Q2 2023

Jul 24, 2023

BUY
$154.35 - $166.11 $21,454 - $23,089
139 Added 2.41%
5,918 $979,000
Q1 2023

May 11, 2023

BUY
$151.05 - $180.26 $3,625 - $4,326
24 Added 0.42%
5,779 $895,000
Q4 2022

Jan 18, 2023

BUY
$160.2 - $179.79 $16,821 - $18,877
105 Added 1.86%
5,755 $0
Q3 2022

Oct 14, 2022

BUY
$161.33 - $179.52 $37,428 - $41,648
232 Added 4.28%
5,650 $923,000
Q2 2022

Jul 27, 2022

BUY
$168.19 - $186.01 $58,025 - $64,173
345 Added 6.8%
5,418 $962,000
Q1 2022

Apr 14, 2022

BUY
$158.14 - $179.59 $802,244 - $911,060
5,073 New
5,073 $899,000
Q4 2021

Jan 18, 2022

SELL
$155.93 - $173.01 $798,049 - $885,465
-5,118 Closed
0 $0
Q3 2021

Oct 18, 2021

SELL
$161.5 - $179.47 $3,391 - $3,768
-21 Reduced 0.41%
5,118 $827,000
Q2 2021

Aug 03, 2021

SELL
$159.48 - $171.07 $4,624 - $4,961
-29 Reduced 0.56%
5,139 $847,000
Q1 2021

Apr 27, 2021

BUY
$153.07 - $170.48 $3,520 - $3,921
23 Added 0.45%
5,168 $849,000
Q4 2020

Jan 29, 2021

BUY
$137.11 - $157.38 $21,526 - $24,708
157 Added 3.15%
5,145 $810,000
Q3 2020

Oct 20, 2020

SELL
$140.38 - $153.83 $22,741 - $24,920
-162 Reduced 3.15%
4,988 $743,000
Q2 2020

Jul 31, 2020

SELL
$128.81 - $155.51 $1,674 - $2,021
-13 Reduced 0.25%
5,150 $724,000
Q1 2020

May 04, 2020

SELL
$111.14 - $153.99 $13,781 - $19,094
-124 Reduced 2.35%
5,163 $677,000
Q4 2019

Feb 21, 2020

BUY
$127.5 - $146.44 $80,452 - $92,403
631 Added 13.55%
5,287 $771,000
Q3 2019

Oct 22, 2019

BUY
$126.95 - $142.14 $178,999 - $200,417
1,410 Added 43.44%
4,656 $602,000
Q2 2019

Aug 08, 2019

SELL
$131.15 - $144.24 $9,180 - $10,096
-70 Reduced 2.11%
3,246 $452,000
Q1 2019

Apr 12, 2019

BUY
$125.72 - $139.79 $46,642 - $51,862
371 Added 12.6%
3,316 $464,000
Q4 2018

Jan 18, 2019

SELL
$122.84 - $147.84 $12,529 - $15,079
-102 Reduced 3.35%
2,945 $380,000
Q3 2018

Oct 19, 2018

SELL
$121.58 - $142.88 $21,276 - $25,004
-175 Reduced 5.43%
3,047 $421,000
Q2 2018

Jul 31, 2018

BUY
$119.4 - $131.76 $67,102 - $74,049
562 Added 21.13%
3,222 $391,000
Q1 2018

Apr 16, 2018

SELL
$125.1 - $148.14 $8,757 - $10,369
-70 Reduced 2.56%
2,660 $341,000
Q4 2017

Feb 09, 2018

BUY
$131.22 - $143.62 $358,230 - $392,082
2,730
2,730 $381,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $431B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track De Dora Capital, Inc. Portfolio

Follow De Dora Capital, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of De Dora Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on De Dora Capital, Inc. with notifications on news.